|1.||Steffensen, Knut R: 10 articles (07/2015 - 01/2007)|
|2.||Kaul, Deepak: 9 articles (08/2013 - 10/2003)|
|3.||Gustafsson, Jan-Åke: 8 articles (05/2014 - 08/2011)|
|4.||Gustafsson, Jan-Ake: 8 articles (08/2013 - 06/2005)|
|5.||Tontonoz, Peter: 8 articles (06/2012 - 06/2003)|
|6.||Liao, Shutsung: 8 articles (07/2011 - 11/2004)|
|7.||Hiipakka, Richard A: 7 articles (07/2011 - 11/2004)|
|8.||Kokontis, John M: 6 articles (07/2011 - 11/2004)|
|9.||Warner, Margaret: 5 articles (08/2012 - 02/2008)|
|10.||Collins, Jon L: 5 articles (08/2011 - 02/2003)|
12/01/2011 - "Although animal studies indicate that liver X receptor alpha (LXRα) might influence risk of atherosclerosis, data in humans remain scarce. "
05/01/2008 - "Although a range of studies indicated Liver X receptor (LXR) activation inhibited the development of atherosclerosis in animal models, the mechanism of this effect for LXR agonists has not been fully understood. "
04/01/2003 - "Although potentially undesirable effects of liver X receptor activation on triglyceride metabolism have been observed, recent in-vivo studies confirm that the overall trend is a reduction of atherogenesis. "
06/01/2015 - "Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis."
02/01/2014 - "Liver X receptor (LXR) activators decrease atherosclerosis in mice. "
|2.||Type 2 Diabetes Mellitus (MODY)
05/27/2008 - "Upregulation of liver X receptor dramatically reduced foam cell formation in macrophages from patients with type 2 diabetes mellitus. "
01/01/2010 - "Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)."
08/01/1997 - "Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients."
|3.||Memory Disorders (Memory Loss)
|4.||Diabetic Nephropathies (Diabetic Nephropathy)
07/13/2015 - "In this issue of Cancer Cell, Flaveny and colleagues target the liver-X-receptor with an inverse agonist and show that key glycolytic and lipogenic genes are suppressed, leading to apoptosis of tumor cells without an effect on non-malignant cells. "
07/13/2015 - "Are Synthetic Compounds that Silence the Liver-X-Receptor the Next Generation of Anti-cancer Drugs?"
04/15/2014 - "Liver X receptor: from metabolism to cancer."
08/26/2013 - "We report that tumor-derived oxysterols recruit protumor neutrophils in a liver X receptor (LXR)-independent, CXCR2-dependent manner, thus favoring tumor growth by promoting neoangiogenesis and immunosuppression. "
01/01/2010 - "Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses."
|2.||Peroxisome Proliferator-Activated Receptors (PPAR)
|4.||Amyloid (Amyloid Fibrils)
|10.||pregnane X receptor
|1.||Transplantation (Transplant Recipients)